Walgreens Severe Honey Lemon Throat Drops

Description

Walgreens Severe Honey Lemon Throat Drops are formulated to provide relief for sore throats. Each drop contains a blend of honey and lemon flavors, designed to soothe irritation. The product is available in a package containing 45 drops. The dosage form is a lozenge, which is intended for oral use. The appearance of the drops is consistent with standard throat lozenges, characterized by a smooth texture and a distinct honey lemon flavor profile.

Uses and Indications

This drug is indicated for the temporary relief of occasional minor irritation and pain associated with sore throat and sore mouth.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and over are instructed to dissolve 1 drop slowly in the mouth. This process may be repeated every two hours as needed or as directed by a healthcare professional.

The product is not recommended for use in children under 12 years of age.

Administration should be conducted orally, ensuring that the drop is fully dissolved in the mouth before swallowing.

Contraindications

There are no contraindications listed for this product. However, it is essential to adhere to the recommended dosage guidelines to ensure safe and effective use. Exceeding the recommended dosage may lead to adverse effects.

Warnings and Precautions

Severe sore throat symptoms warrant immediate medical attention. If a patient experiences a sore throat that is severe, persists for more than two days, or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, it is imperative to consult a healthcare professional without delay. Additionally, this product should not be used for more than two days and is contraindicated for children under 12 years of age.

Patients should discontinue use and seek medical advice if a sore mouth does not show improvement within seven days, or if there is persistent or worsening irritation, pain, or redness. These symptoms may indicate a more serious condition that requires further evaluation.

While no specific emergency medical instructions are provided, healthcare professionals should remain vigilant for any signs of severe adverse reactions in patients. General precautions should be observed, although specific guidelines are not detailed in the current information.

Currently, there are no recommended laboratory tests associated with the safe use of this product. However, healthcare providers should exercise clinical judgment and consider appropriate monitoring based on individual patient circumstances.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this product. Serious adverse reactions include severe sore throat, particularly if it is accompanied by difficulty in breathing, fever, headache, rash, swelling, nausea, or vomiting. In such cases, patients are advised to consult a doctor promptly.

Common adverse reactions may involve irritation, pain, or redness in the oral cavity. If these symptoms persist or worsen, patients should discontinue use and seek medical advice. Additionally, if a sore mouth does not show improvement within 7 days, it is recommended that patients consult a healthcare professional.

Patients should be cautioned against using the product for more than 2 days and should not administer it to children under 12 years of age. These precautions are essential to ensure safety and mitigate the risk of serious adverse reactions.

Drug Interactions

There are no reported drug interactions associated with the use of this medication. Additionally, no interactions with laboratory tests have been identified. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Walgreens Severe Honey Lemon Throat Drops (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not be administered this medication. There are no established safety or efficacy profiles for this age group, and its use is contraindicated in children 12 years and under.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor patients closely for any signs or symptoms that may arise following an overdose. Common symptoms may include, but are not limited to, alterations in vital signs, neurological changes, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Supportive care is the cornerstone of management, which may involve the following steps:

1. Assessment: Conduct a thorough evaluation of the patient's clinical status, including vital signs and level of consciousness.

2. Supportive Care: Provide symptomatic treatment as necessary, which may include intravenous fluids, oxygen supplementation, or other interventions based on the patient's condition.

3. Consultation: Engage with a poison control center or toxicology specialist for guidance on specific management strategies tailored to the substance involved.

Healthcare professionals should remain vigilant and prepared to implement appropriate interventions based on the clinical presentation of the patient.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Reports of adverse events have been received through voluntary reporting and surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events or side effects associated with the use of the product. For inquiries or to report an adverse event, individuals may contact the designated helpline at 1-800-245-2898, available Monday through Friday from 9 AM to 4 PM EST.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of the reach of children to prevent accidental ingestion. Patients should be instructed to stop using the product and consult a doctor if their sore mouth does not improve within 7 days, or if they experience persistent or worsening irritation, pain, or redness.

It is important to emphasize that patients should not exceed the recommended dosage. Additionally, healthcare providers should encourage patients to seek medical advice before using the medication if they have a severe sore throat that is accompanied by difficulty in breathing or lasts more than 2 days. Patients should also be advised to consult a doctor if their sore throat is accompanied by fever, headache, rash, swelling, nausea, or vomiting.

Storage and Handling

The product is supplied in a secure bag, and it is imperative that the bag is not used if it is torn or open, as this may compromise the integrity of the contents.

For optimal storage, the product should be kept in a cool, dry place, away from direct sunlight and moisture. It is essential to handle the product with care to maintain its quality and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Walgreens Severe Honey Lemon Throat Drops, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)